Ularitide

Published

dm+d

Unassigned

New Medicines

Heart failure; acute decompensated, 1st line

Information

New molecular entity
Cardiorentis
Cardiorentis

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Jun 17: Still reported at phase III development stage for Acute HF in EU and U

Category

Synthetic natriuretic peptide
5 December 2012In 2011-12, heart failure (ICD10 I50) accounted for 121,242 finished consultant episodes, 61,130 admissions and 741,973 bed days (https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics), with 5,378 deaths reported in 2011 (www.ons.gov.uk).
Heart failure; acute decompensated, 1st line
Intravenous infusion

Evidence based evaluations

7 January 2016NIHR